Objectives: To update the cost of urinary incontinence (UI) for year 2000 and compare it with the cost of overactive bladder (OAB).
Methods: Using the cost-of-illness framework, disease epidemiologic data were combined with treatment rates, consequence probabilities, and average cost estimates. All costs reflect the costs during 2000.
Results: The total cost of UI and OAB was 19.5 billion dollars and 12.6 billion dollars, respectively (year 2000 dollars). With UI, 14.2 billion dollars was borne by community residents and 5.3 billion dollars by institutional residents. With OAB, 9.1 and 3.5 billion dollars, respectively, was incurred by community and institutional residents.
Conclusions: OAB affected 34 million individuals compared with 17 million with UI. Despite the differences in epidemiology, the total and per-person costs of UI were higher than the OAB costs because OAB individuals without incontinent episodes incurred fewer costs, on average.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.urology.2003.10.037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Progress, Pitfalls, and Impact of AI-Driven Clinical Trials.
Clin Pharmacol Ther
December 2024
Insilico Medicine US Inc, Cambridge, Massachusetts, USA.
Since the deep learning revolution of the early 2010s, significant efforts and billions of dollars have been invested in applying artificial intelligence (AI) to drug discovery and development (AIDD). However, despite high expectations, few AI-discovered or AI-designed drugs have entered human clinical trials, and none have achieved clinical approval. In this perspective, we examine the challenges impeding progress and highlight opportunities to harness AI's potential in transforming drug discovery and development.
View Article and Find Full Text PDFTherapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenies of rheumatoid arthritis.
Arthritis Res Ther
December 2024
Symbiosis School of Biological Sciences (SSBS), Faculty of Medical & Health Sciences, Symbiosis International (Deemed University), Lavale, Pune, 412115, India.
In an age where there is a remarkable upsurge in developing precision medicines, antibody-drug conjugates (ADCs) have emerged as a progressive therapeutic strategy. ADCs typically consist of monoclonal antibodies (mAb) conjugated to the cytotoxic payloads by utilizing a linker, combining the benefits of definitive target specificity of mAbs and potent killing impact of payload to achieve precise and efficient elimination of target cells. In addition to their well-established role in oncology, ADCs are currently demonstrating encouraging potential in addressing the unmet requirements in the treatment of autoimmune conditions such as rheumatoid arthritis (RA).
View Article and Find Full Text PDFDisaster Psychiatry: An urgent field in psychiatry posing a pertinent question.
Psychiatriki
December 2024
Associate Professor of Psychiatry, University of Thessaly Medical School Head, Department of Psychiatry, University Hospital of Larisa Chair, World Psychiatric Association, Section of Disaster Psychiatry.
Disasters, both natural and man-made, impose a significant burden on the mental health of individuals, communities, and societies. The frequency and intensity of disasters is increasing; 3-4 fold compared to the last century, with 400-500 significant disasters/year, affecting >1.5 billion people worldwide and costing 250-400 billion dollars/year.
View Article and Find Full Text PDFEstimated global and regional economic burden of genital herpes simplex virus infection among 15-49 year-olds in 2016.
BMC Glob Public Health
July 2024
Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Background: Globally, herpes simplex virus (HSV)-2 and -1 infections contribute to a large disease burden, but their full economic consequences remain unclear. This study aims to estimate the global economic impact of genital HSV-2 and HSV-1 infection and its consequences for people with genital ulcer disease, neonatal herpes, and human immunodeficiency virus (HIV) infection attributable to HSV-2.
Methods: Using a societal perspective, the economic burden was calculated at the country level and presented by World Health Organization (WHO) regions and World-Bank income levels.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!